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Abstract 
Background: Enterobacteriaceae are among the most common pathogens that are responsible for serious commu-
nity-acquired, hospital-acquired, and health-care associated infections. The emergence and spread of carbapenem-
resistant Enterobacteriaceae (CRE) have become an increasing concern for healthcare services worldwide. Infections 
caused by these bacteria have been associated with significant morbidity and mortality and treatment options have 
been limited. The rapid and accurate detection of carbapenem resistance in these bacteria is important for infection 
control. The aim of this study was to investigate the phenotypic and genotypic features of CRE strains isolated in a 
tertiary-level reference hospital in Turkey.
Methods: A total of 181 CRE strains were included in the study. Antimicrobial susceptibility rates were tested using 
Vitek 2 system. Modified Hodge test (MHT) was performed using meropenem and ertapenem discs. Metallo-β-
lactamase antimicrobial gradient test (E-test MBL strips) were used for evaluation of metallo-β-lactamase production. 
A multiplex PCR was used for detection of carbapenems resistance genes (IMP, VIM, KPC, NDM-1 and OXA-48).
Results: The OXA-48 gene was detected in 86 strains, NDM-1 gene in six strains, VIM gene in one strain. IMP and KPC 
genes were not identified. Three strains produced both OXA-48 and NDM-1 and one strain produced both OXA-48 
and VIM. In two patients more than one genus of OXA-48 positive CREs was isolated. Ninety-two of the isolates were 
multidrug-resistant. One hundred and ten isolates were MHT with meropenem (MEM-MHT) positive and 109 isolates 
were MHT with ertapenem (ERT-MHT) positive. Nine of the isolates were positive with E-test MBL strips. The sensitivity 
of MEM-MHT and ERT-MHT for detection of OXA-48 was 70.9 and 70.6 %, respectively. MEM-MHT was found highly 
discriminative for OXA-48 Escherichia coli (p < 0.001). The sensitivity of E-test MBL for NDM-1 was 66.7 %. A statistically 
significant correlation was observed between OXA-48 gene and MHT positivity and between NDM-1, VIM gene and 
E-test MBL positivity (p < 0.001).
Conclusions: OXA-48 gene is spreading rapidly to many different species of Enterobacteriaceae in the hospital 
environment. While OXA-48 is still the most common source of carbapenem resistance in Enterobacteriaceae in our 
country, NDM-1 is increasingly being isolated from patients without a history of foreign contact.
Keywords: Enterobacteriaceae, Carbapenem resistance, OXA-48, NDM-1, VIM, Modified Hodge test, Multiplex PCR, 
Multidrug resistance
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Background
Enterobacteriaceae are common human pathogens 
and colonizers of the human intestinal tract which can 
cause a broad range of diseases including urinary tract 
infections, pneumonia, bloodstream infections, intra-
abdominal, skin and soft tissue infections in both com-
munity and hospital settings [1–4]. Antibiotic resistance 
in Enterobacteriaceae is an important public health prob-
lem. Because these microorganisms are associated with 
increased length of hospital stay, the cost of treatment, 
mortality and morbidity [5–8].
Dissemination of infections caused by extended-spec-
trum β-lactamases (ESBL) and AmpC β-lactamases-
producing Enterobacteriaceae has compromised 
susceptibility to cephalosporins in many areas of the 
world and has led to increased use of carbapenems which 
are stable antibiotics against these enzymes. However 
widespread use of carbapenems resulted in the emer-
gence of carbapenem-resistant Enterobacteriaceae (CRE) 
[3, 4, 6, 9, 10].
Mainly two different mechanisms are responsible for 
carbapenem resistance in Enterobacteriaceae: (i) hyper 
production of ESBL or AmpC enzymes combined with 
porin loss or alteration or upregulated efflux pump and/
or (ii) production of carbapenem-hydrolyzing carbapen-
emases [1, 6, 11–13].
In 1993, NmcA in Enterobacter cloacae was identified 
as the first carbapenemase enzyme in Enterobacteriaceae 
[4, 10]. Since then, outbreaks caused by carbapenemase-
producing Enterobacteriaceae (CPE) have been reported 
from various regions of the world [1, 4, 14].
Carbapenemases are categorized in Ambler classifica-
tion system as follows, the class A carbapenemases (GES, 
KPCs) which are inhibited by clavulanic acid; the class B 
or metallo-β-lactamases (VIM, IMP, NDMs) which are 
inhibited by ethylene diamine tetra-acetic acid (EDTA); 
and the class D oxacillinases which are not affected by 
clavulanic acid or EDTA [3, 7, 8, 14, 15].
Plasmid-mediated carbapenemase production is the 
most important and common cause of carbapenem 
resistance in CRE [3, 7, 9, 12, 16]. The emergence of plas-
mids containing carbapenemase genes was considered 
as a serious health threat because it may ease the spread 
of carbapenem resistance [17]. Also, carbapenem-resist-
ant isolates frequently carry additional antimicrobial 
resistance genes to other classes of antibiotics including 
fluoroquinolones, aminoglycosides, trimethoprim—sul-
famethoxazole, and this limits the treatment options [1, 
6, 9, 10, 13, 18].
A limited number of published data from our country 
about carbapenem resistance in Enterobacteriaceae other 
than carbapenem-resistant Klebsiella pneumonia (CRKP) 
are available.
The aim of this study was to investigate phenotypic and 
genotypic characteristics of carbapenem resistance in 
CRE isolated from patients in our hospital.
Methods
Setting and study design
This prospective study was conducted over a period of 
13  months between January 31st 2013–February 14th 
2014 in Medical Microbiology Laboratory of Ankara 
Numune Research and Training Hospital which is a 1200 
bed capacity tertiary-level reference hospital with surgi-
cal, medical, orthopaedic and intensive care units and 
serves not only a population of 4,000,000 inhabitants but 
also the surrounding cities.
In this period, a total of 6426 Enterobacteriaceae spe-
cies were isolated from different clinical specimens 
(blood, urine, wound, tracheal aspirate, abscess, etc.) sent 
to our laboratory. Clinical samples were analysed with 
standard laboratory techniques.
Bacterial strains and antimicrobial susceptibility testing
All Enterobacteriaceae isolates at the time of isolation 
were identified using Vitek 2 automated system (bioMé-
rieux, France) with ID-GNB card and then confirmed by 
MALDI Biotyper (Bruker, Germany). Antibiotic suscep-
tibility tests were done using vitek AST-GN cards. Sus-
ceptibilities to ampicillin (AMP), amoxicillin-clavulanic 
acid (AMC), piperacillin-tazobactam (TZP), cefuroxime 
(CXM), cefuroxime-axetil (CAE), cefoxitin (FOX), cef-
tazidime (CAZ), ceftriaxone (CRO), cefepime (FEP), 
ertapenem (ERT), imipenem (IPM), meropenem (MEM), 
amikacin (AMK), gentamicin (GEN), ciprofloxacin (CIP), 
colistin (CST), trimethoprim-sulfamethoxazole (SXT) 
were tested. CLSI 2013 M100-S23 breakpoint values were 
used [19]. For colistin the CLSI recommendation for Aci-
netobacter spp. were used [19, 20]. Escherichia coli ATCC 
25922 and Pseudomonas aeruginosa ATCC 27853 were 
used as quality control strains.
Isolates were considered as CRE if they were found 
resistant or intermediate to one or more of the carbap-
enems (ERT, IPM and MEM). A total of 181 (2.82 %) iso-
lates were identified as CRE and were included in this 
study. Minimal inhibitory concentration (MIC) of ERT, 
IPM and MEM were also tested by E-test. E-test results 
were interpreted according to the CLSI 2013 criteria [19].
Phenotypic methods for detecting carbapenemase activity 
testing and ESBL production
Modified Hodge test (MHT) was used for screening car-
bapenemase production using ERT and MEM according 
to CLSI guidelines [19]. Metallo-β-lactamase production 
was investigated with metallo-β-lactamase antimicrobial 
gradient test which is IPM and IPM/EDTA E-test MBL 
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strips (bioMérieux, France). A ratio of MICIPM/MICIPM/
EDTA ≥8 considered presumptive of metallo-β-lactamase. 
ESBL production was evaluated by CLSI screening and 
confirmatory test methods [19].
Molecular analysis of carbapenemase genes
For investigation of carbapenemases genes a multiplex 
PCR (hyplex® SuperBug ID, Amplex, Germany) was 
used. This system can identify metallo-β-lactamase genes 
such as blaVIM(1–13), blaIMP(1–22) and blaNDM-1, oxacillinase 
genes such as blaOXA-48-like encoding genes (including. 
blaOXA-162, OXA-181, OXA.204 and blaOXA-244) and all variants 
of blaKPC(1-10) genes.
DNA was extracted from bacteria grew in 24-h cul-
ture. After PCR reactions, amplification products were 
heat-denaturated to obtain single-stranded DNA and 
loaded to microtiter plates coated with specific probes. 
Hybridization reaction principle was used to investigate 
carbapenemase gene loci in loaded DNA. Hybridization 
of complementary sequences was then detected using 
ELISA principle. The colour formed by the chromogenic 
reaction was then measured by a photometer at a wave-
length of 450 nm.
Statistical analysis
All data were evaluated by using SPSS for Windows ver-
sion 11.5. We used Chi square test and Fischer’s exact 
test to relate genes and MHTs for categorical data, and 
we also calculated screening test results. Descriptive sta-
tistics, frequencies and percentages were given. The sta-
tistical significance level was set to 0.05.
Results
CRE isolates
During the study period 181 CRE were identified from 
6426 Enterobacteriaceae isolates. The most common spe-
cies were Klebsiella pneumoniae (69, 38.12  %), followed 
by Serratia marcescens (33, 18.23  %), Morganella mor-
ganii (17, 9.39  %), Proteus mirabilis (17, 9.39  %), E. coli 
(13, 7.18  %), Enterobacter cloacae (13, 7.18  %), Entero-
bacter aerogenes (10, 5.52  %), Citrobacter freundii (2, 
1.1  %), Raoultella planticola (2, 1.1  %), Proteus vulgaris 
(1, 0.55  %), Providencia rettgeri (1, 0.55  %), Providencia 
stuartii (1, 0.55  %), Cronobacter sakazakii (1, 0.55  %), 
Klebsiella oxytoca (1, 0.55 %).
The majority of strains were isolated from internal 
medicine intensive care unit (ICU) (49, 27.07  %). This 
was followed by post anesthesia care unit (PACU) (18, 
9.94  %), surgical ICU (10, 5.52  %), general surgery unit 
(10, 5.52  %), burn unit (9, 4.97  %), urology (9, 4.97  %), 
and emergency internal medicine (9, 4.97 %). Remaining 
isolates were isolated from other clinics. Most of the 181 
isolates were collected from blood (59 isolates, 32.6  %), 
from urine (49, 27.07 %), and from wounds (31, 17.13 %). 
The remaining isolates were from tracheal aspirates (21, 
11.6 %), abscess culture (9, 4.97 %), catheter (4, 2.21 %), 
pleural fluid (3, 1.66 %), peritoneal fluid (1, 0.55 %), bile 
(1, 0.55  %), sputum (1, 0.55  %), rectal swab (1, 0.55  %), 
cerebrospinal fluid (CSF) (1, 0.55 %). Table 1 shows distri-
bution of Enterobacteriaceae species according to clinical 
samples.
Phenotypic tests for carbapenemase production 
and carbapenemase genes identified by multiplex PCR
When 181 CRE isolates were analyzed with MHT with 
MEM (MEM-MHT) and MHT with ERT (ERT-MHT) 
for carbapenemase production; 110 (60.8 %) isolates were 
found positive with MEM-MHT and 109 (60.2  %) iso-
lates were positive with ERT-MHT. Only nine (5 %) of the 
isolates were tested positive with E-test MBL strips for 
metallo-β-lactamase production.
In 86 (47.51 %) of the isolates, the blaOXA-48 gene was 
detected by multiplex PCR. Six isolates (3.33  %) were 
blaNDM-1 gene positive. In one strain (0.56  %) blaVIM 
gene was found positive. A breakdown of carbapen-
emase positive isolates is presented in Table  2. At least 
one carbapenemase-encoding gene was found positive in 
90 (49.72  %) of the isolates. In four of the strains, mul-
tiple carbapenemase genes were identified. Three of the 
blaNDM-1 positive K. pneumoniae also possessed blaOXA-48 
gene. In one of the K. pneumoniae, blaVIM gene was 
detected alongside blaOXA-48 gene. The blaIMP and blaKPC 
genes were not detected in any of the isolates.
MEM-MHT was positive in 78 of the 86 (90.69  %) 
blaOXA-48 positive isolates. ERT-MHT was positive in 77 
of the 86 (89.53 %) blaOXA-48 positive isolates. All NDM 
and VIM positive isolates were positive with MHT and 
E-test MBL. NDM-1-positive E. cloacae were both MHT 
and E-test MBL positive. MEM-MHT, ERT-MHT results 
according to different OXA-48 positive CRE isolates was 
shown in Table 3. Sensitivity, specificity, negative predic-
tive value (NPV) and positive predictive value (PPV) of 
MEM-MHT and ERT-MHT for blaOXA-48 positive isolates 
were given in Table 4.
There was a statistically significant correlation between 
blaOXA-48 gene positivity and MEM-MHT positivity 
(p < 0.001). There was also a statistically significant cor-
relation between blaOXA-48 gene positivity and ERT-MHT 
positivity (p  <  0.001). MEM-MHT was found highly 
discriminative for blaOXA-48-positive E. coli (p  <  0.001). 
Accuracy rate of MEM-MHT and ERT-MHT were not 
good for other CRE species. High rate of false positive 
and negative results were observed.
The sensitivity of E-test MBL for blaNDM-1 positive iso-
lates was 66.7 %, specificity was 100 %, NPV 98.3 %, PPV 
100  %. There was a statistically significant correlation 
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between blaNDM-1 positivity and E-test MBL positivity 
(p  <  0.001). When blaNDM-1 positive and blaVIM positive 
isolates were considered together sensitivity of E-test 
MBL was 77.8 %, specificity was 100 %, NPV 98.9 %, PPV 
100 %.
Carbapenemase genes were detected in 31 (36.05  %) 
strains isolated from urine samples, 21 (24.42 %) strains 
isolated from blood samples, 16 (18.60  %) strains iso-
lated from tracheal aspirate samples, 11 (12.79 %) strains 
isolated from wound samples, 4 (4.65  %) strains from 
abscess samples, 3 (3.49 %) strains isolated from catheter 
samples, 1 (1.16 %) strain from sputum, 1 (1.16 %) strain 
from peritoneal fluid, 1 (1.16 %) strain from isolated from 
bile.
Carbapenemase genes were detected mostly in 18 
(20.93  %) samples isolated from patients from internal 
ICU. This was followed by 13 (15.12 %) samples isolated 
from PACU patients, 9 (10.47  %) samples from surgical 
ICU, 6 (6.77 %) samples from urology patients, 5 (5.81 %) 
samples from emergency internal medicine patients, 4 
(4.65  %) samples from neurosurgery patients 4 (4.65  %) 
samples from general surgery patients, 4 (4.65 %) samples 
from emergency medicine patients and 23 samples from 
other hospital units.
Isolation of multiple CRE from the same patient
In two patients more than one genus of CREs was iso-
lated, and the blaOXA-48 gene was positive in all these 
isolates. First was a patient from surgical ICU. OXA-
48-positive K. pneumoniae was isolated from wound 
sample then 2  days later OXA-48-positive K. oxytoca 
was isolated from tracheal aspirate and then 4 days later 
OXA-48-positive E. coli was isolated from an abscess. 
The second was a patient from bone marrow transplanta-
tion (BMT) unit. An OXA-48-positive E. cloacae was iso-
lated from urine and 9 days later OXA-48-positive E. coli 
was isolated from blood.
Antimicrobial susceptibility results of carbapenemase 
negative and positive CRE
When all 181 CRE isolates were considered; 95.58 % were 
resistant to AMP, 91.16 % were resistant to AMC, 80.11 % 
Table 1 Species and specimen distribution of 181 carbapenem-resistant Enterobacteriaceae
*Bile, sputum, rectal swab, peritoneal fluid, cerebrospinal fluid
Species Specimen type (n)
Blood Urine Wound Trachael aspirate Abscess Catheter Pleural fluid Other* Total
K. pneumoniae 18 25 8 10 3 4 1 69
S. marcescens 29 1 1 1 1 33
M. morganii 2 3 9 2 1 17
P. mirabilis 3 7 5 2 17
E. coli 3 5 1 3 1 13
E. cloacae 1 4 4 3 1 13
E. aerogenes 1 2 4 2 1 10
C. freundii 1 1 2
R. planticola 1 1 2
P. vulgaris 1 1
P. rettgeri 1 1
P. stuartii 1 1
C. sakazakii 1 1
K. oxytoca 1 1
Total 59 49 31 21 9 4 3 5 181
Table 2 Distribution of positive carbapenemase gene loci according to bacteria types





















OXA-48 52 (75.36) 5 (15.15) 3 (17.65) 6 (35.29) 8 (61.54) 3 (23.08) 5 (50) 1 (50) 1 (50) 1 (100) 1 (100) 86 (47.51)
NDM-1 5 (7.25) 0 0 0 0 1 (7.69) 0 0 0 0 0 6 (3.31)
VIM 1 (1.45) 0 0 0 0 0 0 0 0 0 0 1 (0.55)
Page 5 of 11Baran and Aksu  Ann Clin Microbiol Antimicrob  (2016) 15:20 
were resistant to TZP, 80.11  % were resistant to CXM, 
82.32 % were resistant to CAE, 76.80 % were resistant to 
FOX, 60.22 % were resistant to CAZ, 68.51 % were resist-
ant to CRO, 51.38 % were resistant to FEP, 55.80 % were 
resistant to ERT, 94.47 % were resistant to IPM, 44.75 % 
were resistant to MEM, 23.20 % were resistant to AMK, 
39.23 % were resistant to GEN, 46.96 % were resistant to 
CIP, 46.41 % were resistant to CST, 38.67 % were resistant 
to SXT. Antimicrobial resistance results of each species 
were shown in Table 5.
Ninety-two of the 181 isolates (50.8 %) were multidrug-
resistant which was defined as being resistant to three 
or more functional classes of drugs simultaneously by 
Magiorakos et al. [21]. Fifty-one of the 69 K. pneumoniae 
isolates were found to be multidrug-resistant, and four of 
them were found to be resistant to all tested antibiotics. 
Eight of the 13 E. coli, 10 of 17 P. mirabilis, eight of 17 M. 
morganii, eight of the 13 E. cloacae, one the 10 E. aero-
genes, two of the two C. freundii, one the two R. plan-
ticola, one of one P. rettgeri, one of one P. stuartii, and 
only one of the 33 S. marcescens were multidrug-resist-
ant. Fifty three (61.62 %) of 86 OXA-48 positive isolates 
and 39 (41.05 %) of the 95 OXA-48 negative isolates were 
multidrug-resistant. There were more multidrug-resist-
ant isolates in OXA-48 positive isolates than OXA-48 
negative ones, and this difference was statistically signifi-
cant (p < 0.01). All metallo-β-lactamase (NDM-1, VIM) 
positive isolates were found to be multidrug-resistant 
(p  <  0.01). There was a statistically significant correla-
tion between having one of the carbapenemase genes and 
being multidrug-resistant (p < 0.001).
Most of the K. pneumoniae, E. coli and E. cloacae iso-
lates were resistant to carbapenems, beta-lactam/beta-
lactamase inhibitor combinations, third and fourth 
generation cephalosporins, CIP and SXT. Thirty-seven 
out of 69 K.pneumoniae were found to be susceptible 
to AMK, and 25 were susceptible to GEN. Ten of the 
K. pneumoniae were found to be resistant to CST. One 
E.cloacae and one E.coli isolate were found to be resist-
ant to CST. Twenty-three of K. pneumoniae isolates were 
identified as ESBL producers.
Fifty-four of the 69 K. pneumoniae (78.26 %) had a least 
a carbapenemase gene. Eighteen of the carbapenemase-
positive K. pneumoniae were also ESBL positive. Both 
Table 3 Distribution of MEM-MHT, ERT-MHT results according to carbapenem- resistant Enterobacteriaceae isolates











All isolates 181 110 71 109 72
OXA-48 positive isolates 86 78 8 77 9
K. pneumoniae 69 56 13 55 14
OXA-48 positive K. pneumoniae 52 50 2 51 1
S. marcescens 33 10 23 6 27
OXA-48 positive S. marcescens 5 2 3 1 4
M. morganii 17 8 9 9 8
OXA-48 positive M. morganii 3 3 0 3 0
P. mirabilis 17 9 8 10 7
OXA-48 positive P. mirabilis 6 4 2 4 2
E. coli 13 8 5 10 3
OXA-48 positive E. coli 8 8 0 8 0
E. cloacae 13 8 5 8 5
OXA-48 positive E. cloacae 3 3 0 3 0
E. aerogenes 10 7 3 7 3
OXA-48 positive E. aerogenes 5 5 0 5 0
C. freundii 2 0 2 1 1
OXA-48 positive C. freundii 1 0 1 0 1
R. planticola 2 1 1 0 2
OXA-48 positive R. planticola 1 1 0 0 1
P. stuartii 1 1 0 1 0
OXA-48 positive P. stuartii 1 1 0 1 0
K. oxytoca 1 1 0 1 0
OXA-48 positive K. oxytoca 1 1 0 1 0
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carbapenemase-negative and carbapenemase-positive K. 
pneumoniae were found to be 100  % resistant to AMP, 
AMC, TZP and ERT. Carbapenemase-positive K. pneu-
moniae was found to be slightly more resistant to FOX 
(87.04 vs 80 %), CAZ (87.04 vs 86.67 %), CRO (87.04 vs 
86.67 %), FEP (87.04 vs 86.67 %), IPM (96.30 vs 86.67 %), 
MEM (79.63 vs 73.33  %), GEN (64.81 vs 60  %), CST 
(16.67 vs 6.67 %) than carbapenemase-negative K. pneu-
moniae. On the other hand carbapenemase-negative 
K. pneumoniae were more resistant to CXM (93.33 
vs 88.89  %), CAE (93.33 vs 88.89  %), AMK (66.67 vs 
40.74  %), CIP (80 vs 77.78  %), and SXT (73.33 vs 50  %) 
than carbapenemase-positive K. pneumoniae. How-
ever, these differences were not statistically significant 
(p > 0.05).
One of the OXA-48 and NDM-1 positive K.pneumoniae 
was found resistant to all of the tested antibiotics.
Three E.coli isolates were ESBL positive. Eight of the 
OXA-48 positive isolates were found to be multidrug-
resistant. Both OXA-48 positive and negative isolates 
were found to be 100 % resistant to AMP. E. coli which 
posses blaOXA-48 gene were found to be more resistant to 
antibiotics than blaOXA-48 negative E. coli: AMC (100 vs 
80 %), TZP (100 vs 80 %), CXM (100 vs 80 %), CAE (100 
Table 4 Sensitivity, specificity, negative predictive value, positive predictive value of  MEM-MHT, ERT-MHT and  correla-
tion with OXA-48 gene positivity
MEM-MHT modified Hodge test with meropenem, ERT-MHT modified Hodge test with ertapenem, NPV negative predictive value, PPV positive predictive value
Sensitivity  % Specificity  % NPV  % PPV  % Correlation with OXA-48 
gene positivity
All OXA-48 positive isolates MEM-MHT 70.9 88.7 66.3 90.7 p < 0.001
ERT-MHT 70.6 87.5 66.3 89.5 p < 0.001
OXA-48 positive K. pneumoniae MEM-MHT 89.3 84.6 64.7 96.2 p < 0.001
ERT-MHT 92.7 92.9 76.5 98.1 p < 0.001
OXA-48 positive S. marcescens MEM-MHT 20 86.9 71.4 40 p > 0.05
ERT-MHT 16.7 85.2 82.1 20 p > 0.05
OXA-48 positive M. morganii MEM-MHT 37.5 100 64.3 100 p > 0.05
ERT-MHT 33.3 100 57.1 100 p > 0.05
OXA-48 positive P. mirabilis MEM-MHT 44.4 75 54.6 66.7 p > 0.05
ERT-MHT 40 71.4 45.5 66.7 p > 0.05
OXA-48 positive E. coli MEM-MHT 100 100 100 100 p < 0.001
ERT-MHT 80 100 60 100 p < 0.05
OXA-48 positive E. cloacae MEM-MHT 37.5 100 50 100 p > 0.05
ERT-MHT 37.5 100 50 100 p > 0.05
OXA-48 positive E. aerogenes MEM-MHT 71.43 100 60 100 p > 0.05
ERT-MHT 71.43 100 60 100 p > 0.05
Table 5 Antibiotic resistance rates of  most commonly isolated carbapenem-resistant Enterobacteriaceae species in  our 
study
AMC amoxicillin-clavulanic acid, AMK amikacin, AMP ampicillin, CAE cefuroxime-axetil, CAZ ceftazidime, CIP ciprofloxacin, CRO ceftriaxone, CST colistin, CXM 
cefuroxime, ERT ertapenem, FEP cefepime, FOX cefoxitin, GEN gentamicin, IPM imipenem, MEM meropenem, SXT trimethoprim-sulfamethoxazole, TZP piperacillin-
tazobactam
Species Antibiotic resistance rate (%)
AMP AMC TZP CXM CAE FOX CAZ CRO FEP ERT IPM MEM AMK GEN CIP CST SXT
K. pneumoniae 100 100 100 88.41 88.41 85.51 86.96 86.96 86.96 100 92.75 78.26 46.38 63.77 78.26 14.49 55.07
S. marcescens 100 100 30.30 100 100 100 30.30 100 6.06 0 100 0 3.03 0 0 100 0
M. morganii 100 100 52.94 100 100 52.94 58.82 41.18 58.82 0 100 11.76 17.65 11.76 29.41 100 47.06
P. mirabilis 52.94 29.41 17.65 0 0 0 23.53 0 17.65 0 100 5.88 0 29.41 35.29 100 41.18
E. coli 100 92.31 92.31 92.31 84.62 76.92 69.23 76.92 76.92 84.62 84.62 76.92 15.38 53.85 61.54 7.69 61.54
E. cloacae 100 100 69.23 76.92 100 100 61.54 61.54 38.46 84.62 92.31 61.54 30.77 61.54 61.54 7.96 53.85
E. aerogenes 100 100 50 50 60 100 40 30 0 50 90 30 0 0 10 10 0
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vs 60  %), FOX (100 vs 40  %), CAZ (100 vs 20  %), CRO 
(100 vs 40 %), FEP (100 vs 40 %), ERT (100 vs 60 %), IPM 
(100 vs 60 %), MEM(100 vs 40 %), AMK (25 vs 0 %), GEN 
(62.5 vs 20 %), CIP (75 vs 40 %), SXT (62.5 vs 60 %) except 
for CST (0 vs 20 %). Only the differences for FOX, CAZ, 
CRO, FEP, MEM were statistically significant (p < 0.05).
One isolate of E. cloacae was found to produce 
blaNDM-1. This isolate was found to be highly resistant to 
tested antibiotics with high MICs and found to be sus-
ceptible to only to CST. It was isolated from the urine 
sample of a patient who was residing at internal medicine 
unit. When patient’s history was examined, there was no 
history of foreign travel. This patient had a previous his-
tory of use of cephalosporins and carbapenems. Similarly, 
none of the other patients with blaNDM-1 gene positive 
CRE infections had records of foreign travel.
S. marcescens isolates were mostly resistant to beta-
lactam/beta-lactamase inhibitor combinations, second 
and third generation cephalosporins. All were resistant to 
IMP, and all were resistant to CST. All were susceptible to 
ERT, MEM, GEN, CIP and SXT.
M. morganii isolates were mostly resistant to beta-
lactam/beta-lactamase inhibitor combinations, IMP and 
CST. Nearly half of the M. morganii isolates were resist-
ant to FOX, CAZ, CRO, FEP and SXT. All M. morganii 
isolates were susceptible to ERT. Two of the isolates were 
resistant to MEM. Three of the isolates were resistant to 
AMK, two were resistant to GEN, and five were resistant 
to CIP.
P. mirabilis isolates were mostly susceptible to beta-
lactam/beta-lactamase inhibitor combinations, cepha-
losporins and aminoglycosides. All P. mirabilis isolates 
were found to be susceptible to ERT, and only one was 
resistant to MEM. All P. mirabilis isolates were resistant 
to IMP and CST.
All E. aerogenes isolates were susceptible to FEP, ami-
noglycosides (AMK and GEN) and SXT. Only one E. 
aerogenes was found to be resistant to CST, and one was 
resistant to CIP.
In our study K. pneumoniae, E. coli, E. cloacae isolates 
were found highly resistant to ERT, IPM and MEM. S. 
marcescens, M. morganii, P. mirabilis were mostly sus-
ceptible to ERT but highly resistant to IPM. CST was 
found to be most effective antibiotic against K. pneumo-
niae, E. coli, E. cloacae. On the other hand, S. marcescens, 
M. morganii, P. mirabilis, P. vulgaris, P. stuartii, P. rettgeri, 
C. sakazakii were found to be 100  % resistant to CST. 
When 181 CRE are considered AMK (23.20 % resistant) 
and SXT (38.67 % resistant) were found as most effective 
antibiotics. Resistance to CST was 46.41  % overall but 
when the resistance of species with intrinsic resistance 
were excluded (Serratia, Morganella, Proteus, etc.) it was 
12.61 %.
Discussion
CRE are increasingly isolated from community-acquired 
and nosocomial infections [6]. CRE can spread clonally 
from person to person or genes which encode carbapen-
emases can spread horizontally between isolates [2]. This 
is an important health concern because plasmid-encoded 
and easily transferable carbapenemases are involved [10]. 
The most important carbapenemases are KPC, VIM, 
NDM and OXA-48 [6]. CRE infections are highly mortal, 
and treatment options are narrow [7, 10]. Rapid identifi-
cation of carbapenemase-producing strains is crucial for 
preventing hospital infections and outbreaks [7].
Certain risk factors were found to be related to the 
acquirement of CRE infections. These situations are 
being admitted to ICU, central venous catheter presence, 
usage of antibiotic such as cephalosporins, having diabe-
tes mellitus, having surgical procedures, long stay in the 
hospital and being a transplant patient [7]. In our study 
majority of our CRE strains were isolated from ICUs.
The rate of CRE in our hospital during the study period 
was found as 2.82  %. In the United States prevalence 
of CRE was found to be between 1.4–4.2  % [2]. Similar 
CRE isolation rates to our study have been reported from 
many Asian countries: 1.2  % in Lebanon, 4.05  % from 
Malaysia,  <1 in Singapore, 1.2  % in Taiwan, 1.17  % in 
Saudi Arabia [4, 5].
The most common CRE species isolated in the US and 
European countries are K. pneumoniae followed by E. 
aerogenes and E. coli [2, 18]. In accordance to this in our 
study, the most common isolated species was K. pneumo-
niae. But our second most was S. marcescens and third 
most were M. morganii and P. mirabilis.
Our country has a geographical importance for isola-
tion of carbapenemase-producing bacteria. However 
molecular studies regarding carbapenemase resistance 
are limited especially for CRE other than CRKP [7].
After its initial identification from a K. pneumoniae 
strain in 2001 in Turkey, OXA-48 producers have become 
increasingly important causes of nosocomial outbreaks 
in our country [22, 23]. Today OXA-48 producing Enter-
obacteriaceae have spread to Middle East (Lebanon, 
Israel), and North African countries (Morocco, Tunisia, 
Egypt, Libya, Algeria), Mediterranean countries (Greece, 
Spain, Italy, France, Slovenia, Croatia), and European 
countries (Germany, Belgium, Switzerland, the Nether-
lands, the UK), North America (USA), South America 
(Argentina) and Asia (India, Taiwan) [7, 10, 17, 20, 22, 
23]. The blaOXA-48 gene in Enterobacteriaceae is located 
between two identical copies of IS1999, which altogether 
forms composite transposon Tn1999 on a mobilizable, 
self-conjugative plasmid [4, 7, 8, 10, 14, 17, 22–25] In 
previous studies it was shown that blaOXA-48-carrying 
plasmids can transfer both clonally and horizontally [25].
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Initially and most commonly blaOXA-48 gene was iden-
tified in K. pneumoniae. But currently, many other spe-
cies of Enterobacteriaceae are known to possess them, 
such as E. coli, Enterobacter spp., K. oxytoca, C. freundii, 
S. marcescens, M. morganii, P. mirabilis [17, 25]. In our 
study majority of OXA-48 producing isolates were K. 
pneumoniae. There is an ongoing epidemic of blaOXA-48 
positive K. pneumoniae nosocomial infections in our 
hospital since 2010 (personal data). We guess spread to 
other Enterobacteriaceae species was occurred from 
these K. pneumoniae isolates. Interestingly, during our 
study period more than one genus of blaOXA-48 gene 
positive CRE were isolated in two patients. This suggests 
horizontal interspecies dissemination. The blaOXA-48-like 
genes were known to be located on conjugative plas-
mids of IncL/M incompatibility group which can transfer 
between different species of Enterobacteriaceae [25]. The 
blaOXA-48 can successfully spread to different enterobacte-
rial species with the help of high transfer efficiency of the 
plasmids that carry this gene [23]. This explains the inter-
species transmission of the blaOXA-48 gene.
Arana et al. have reported they have recovered four dif-
ferent CRE species (K. pneumoniae, E. coli, S. marcescens, 
C. freundii) from a patient hospitalized for 4  months. 
These bacteria all had the blaOXA-48 gene. They mentioned 
the great ability of OXA-48 carbapenemase to spread 
among different enterobacterial species [26].
In our country, the blaOXA-48 genes were identified 
previously in K. pneumoniae, E. aerogenes, E.  coli, C. 
freundii, E. cloacae, S. marcescens, P. rettgeri, K. oxytoca 
[24, 27, 28]. To our knowledge, this is the first report of 
blaOXA-48 genes identified in P. mirabilis, M. morganii, P. 
stuartii, R. planticola in Turkey.
The OXA-48 enzyme can successfully hydrolyze peni-
cillins but have poor or no activity against extended-
spectrum cephalosporins and aztreonam. They also have 
a weak carbapenemase activity and cannot show a high 
level of carbapenem resistance. The contribution of other 
factors such as the production of ESBLs or cell wall per-
meability defects are necessary for the increased level of 
resistance to cephalosporins and carbapenems [10, 20, 
22–26]. In other studies, a close association was found 
between OXA-48 enzyme production and expression 
of ESBLs (CTX-M-15, SHV) [8, 10, 13, 17, 20, 24]. Co-
expression of OXA-48 and AmpC enzymes in CRE were 
demonstrated, previously [1].
In our study majority of OXA-48 positive isolates were 
resistant to extended-spectrum cephalosporins and had 
high levels of resistance to carbapenems. These findings 
suggest that other mechanisms of resistance are present 
in our isolates.
On the other hand, metallo-β-lactamases (IMP, 
VIM, and NDM) can yield high levels of resistance to 
carbapenems. But they cannot hydrolyze aztreonam. 
They can be inhibited by EDTA [1, 10, 12]. E-test MBL 
strips use the principle of inhibition of metallo-β-
lactamases by EDTA when IPM is used as a substrate. 
Doyle et  al. said that it is often difficult to interpret 
E-test MBL for investigation of metallo-β-lactamases in 
Enterobacteriaceae because MIC values of IPM are low 
in metallo-β-lactamases -producing Enterobacteriaceae. 
They found that sensitivity of metallo-β-lactamases was 
low, but specificity was high [15]. However, in our study, 
we found nine isolates positive with E-test MBL and 
seven of these isolates had a metallo-β-lactamases gene. 
The sensitivity and specificity of E-test MBL for metallo-
β-lactamases in our study was 77.8 and 100  %, respec-
tively. The false positive results may be due to increased 
outer membrane permeability caused by EDTA used in 
the test [29].
Verona integron encoded metallo-β-lactamase (VIM) 
was first reported from Italy in 1997 [23]. Enterobacte-
riaceae producing VIM enzymes are found prevalently in 
Mediterranean countries. VIM -1- producing Enterobac-
teriaceae are endemic in Greece [10, 22, 23]. In Turkey 
the first detection of VIM-1 was from a K. pneumoniae 
isolate from the urine of three-year-old girl in 2005 by 
Yıldırım et al. [30]. In our study, we identified blaVIM in a 
K. pneumoniae isolate which also had the blaOXA-48 gene. 
This strain was resistant to all tested antibiotics (includ-
ing CST) except SXT. VIM enzymes are found to be 
associated with class1 integrons that carry gene cassettes 
which encode resistance genes to various antibiotics [22].
Another plasmid-mediated metallo-β-lactamases, New 
Delhi metallo-β-lactamase-1 (NDM-1) was first discov-
ered in a K. pneumoniae strain isolated from the urine 
sample of a Swedish patient who was previously hospi-
talized in India in 2009 [3, 10, 22, 23]. Later it spread to 
Balkans and Middle East [1]. NDM-producing Entero-
bacteriaceae are widespread in India, Pakistan, and Bang-
ladesh [22]. The first report of NDM-1 from Turkey was 
in 2011 by Poirel et al. from a K. pneumoniae strain iso-
lated from an allogenic stem cell-transplanted leukemia 
patient who was previously hospitalized in Iraq [7]. The 
second case report in Turkey was from our laboratory 
in 2013 from a K. pneumoniae isolated from the blood 
culture of a Syrian patient [31]. In the present study, we 
detected blaNDM-1 gene in six of the CRE isolates (five K. 
pneumoniae and one E. cloacae). Three of the blaNDM-1 
positive K. pneumoniae isolates were also positive for 
the blaOXA-48 gene. We have found that all six blaNDM-1 
positive isolates were resistant to all β-lactam antibiotics, 
AMK, GEN, CIP, and SXT. Two of the blaNDM-1 positive 
K. pneumoniae isolates were found to be resistant to CST.
In previous studies, similar to our findings NDM-1 pro-
ducing Enterobacteriaceae are found to be often broadly 
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resistant to many other drug classes besides β-lactams. 
NDM-1 producing isolates may carry a diversity of other 
resistance mechanisms such as β-lactamases (AmpC 
cephalosporinases, CTX-M, CMY), other types of car-
bapenemases (OXA-48, KPC and VIM), enzymes that 
cause resistance to aminoglycosides (16S RNA methy-
lase), to quinolones (Qnr), to macrolids (esterases), to 
rifampicin (rifampicin-modifying enzymes), to chloram-
phenicol and SXT, to CST [2, 10, 22, 23].
NDM-1 was most commonly identified in K. pneu-
moniae and E. coli isolates but has been increasingly 
reported in other species of Enterobacteriaceae includ-
ing C. freundii, M. morganii, E. cloacae, K. oxytoca [2, 3, 
6, 22]. This may be because NDM enzymes are encoded 
on highly mobile, conjugative plasmids which facilitate 
horizontal inter- and intraspecies transfer between bac-
teria rather than clonal spread [2, 3, 10]. We have found 
one NDM-1 producing E. cloacae in our study. Previously 
Poirel et  al. reported an NDM-1-producing E. cloacae 
outbreak in a neonatal ICU in Turkey [32]. NDM-1 pro-
ducing E. cloacae previously have been defined as one of 
the most commonly reported CRE species and known to 
cause hospital outbreaks in many other parts of the world 
[3]. In another study from our country, Demir et al. iso-
lated NDM-1 positive S. marcescens and K. oxytoca [6].
This is particularly concerning because NDM isolates 
are highly resistant to many classes of antibiotics and 
have the potential to spread rapidly to many members of 
Enterobacteriaceae and cause nosocomial outbreaks.
The first identified cases of NDM-producing CRE in 
our country had histories of foreign country travel [7, 
31]. None of the NDM cases in our study had a history 
of foreign travel. Similar to our findings in two studies 
from our country conducted by Alp et al. and Sahin et 
al. no international contact history was found in patients 
with NDM-1-producing CRE [7, 33]. This is impor-
tant because it means NDM-1 carbapenem resistance is 
spreading in Turkey.
The development of methods for rapid and accurate 
identification of CRE is necessary for appropriate selec-
tion of antibiotic treatment and prevention of hospital 
outbreaks [7, 9]. Automated antibiotic susceptibility sys-
tems were found to be unreliable for detection of carbap-
enem resistance. These automated systems either over 
or under reported carbapenem resistance [2, 12]. More 
practical molecular methods are needed. In this study, 
we used a hybridization-based multiplex PCR method 
which was reported to have 99  % specificity for OXA-
48 and 100  % for other enzymes [34]. Two other stud-
ies from our country reported to use this multiplex PCR 
method and get accurate results [6, 7]. Demir et al. ana-
lyzed 95 Enterobacteriaceae spp. isolates with this system 
and found blaOXA-48 in 49 isolates, blaNDM-1 in six isolates 
and blaVIM in two isolates. They did not find any carbap-
enemase genes in carbapenemase susceptible strains [6]. 
Sahin et al. found seven blaOXA-48 positive strain and one 
blaNDM-1 positive strain when they studied 43 CRE isolate 
[7].
MHT is known be reliable for detection of KPCs and 
OXA-48-like enzymes but perform poorly for metallo-
β-lactamases (NDMs, VIMs, and IMPs) [2, 9, 12, 15, 24]. 
In a study Doyle et al. found MHT had the sensitivity of 
98 % for detection of KPC-producers, 93 % for OXA-48-
like producers and only 12  % for metallo-β-lactamase 
producers [15]. However, we found that all metallo-β-
lactamase (NDM-1 and VIM) positive bacteria in our 
study were MHT positive.
Another shortcoming of MHT is it can give false-pos-
itive results for carbapenem-resistant but noncarbapen-
emase-producing strains [15]. Also, there is limited data 
on MHT’s performance for CRE other than carbapenem-
resistant K. pneumoniae and E. coli. Hammoud et  al. 
showed MHT gave false-positive results in E. cloacae [4]. 
In this regard, our study was the first study that analyzed 
performance of MHT on many different CRE species. 
The sensitivity of MEM-MHT for blaOXA-48 positive iso-
lates was found 70.9 %; specificity was 88.7 %, sensitivity 
of ERT-MHT for blaOXA-48 positive isolates was 70.6  %, 
specificity was 87.5  %. A good correlation was found 
between blaOXA-48 and MHT positivity.
In our study MHT performed gave best results for 
OXA-48-producing E. coli. MHT’s results for K. pneumo-
niae were acceptable. However, MHT performed poorly 
for S. marcescens, M. morganii, P. mirabilis, E. cloacae, E. 
aerogenes.
MHT gave false positive and negative results for OXA-
48-producing K. pneumoniae, S. marcescens, P. mirabi-
lis, and C. freundii. MHT gave false positive results for 
OXA-48-producing M. morganii, E. cloacae, E. aerogenes.
In many studies, tigecycline and CST were found as 
most effective antimicrobial agents against CRE [1, 5, 
24, 25]. In our study when antibiotic resistance profiles 
of all isolates were considered together, AMK (23.20  %) 
was found as most effective antibiotic, followed by SXT 
(38.67 %). Similar to our findings Wang et al. found that 
AMK susceptibility was very high among the CRE in 
their study [1]. Pollet et  al. found that AMK and GEN 
were the most effective antibiotics followed by SXT when 
cumulative antibiogram of 115 CRE isolates was stud-
ied. In that study, CST and tigecycline were not tested 
[2]. CST resistance rate was high in our study because of 
the strains with intrinsic CST resistance were included 
in cumulative antibiotic resistance profile. On the other 
hand, CST was found as the most effective antibiotic 
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against non-intrinsically CST resistant CRE strains (K. 
pneumoniae, E. coli, E. cloacae, E. aerogenes, R. planti-
cola, K. oxytoca).
We have found that 92 of the 181 isolates were multid-
rug-resistant. The number of multidrug-resistant strains 
in OXA-48 producing isolates were slightly more than 
OXA-48 negative ones, and this difference was statisti-
cally significant. All metallo-β-lactamase positive iso-
lates were multidrug-resistant. In previous studies, it was 
shown that the same plasmids that carry carbapenemase 
genes can often carry resistance genes to other antibiot-
ics, and the rate of multidrug resistance among CRE is 
high [14, 24, 25].
Hammoudi et  al. in their study found that OXA-48 
positive S. marcescens remained susceptible to most 
tested aminoglycosides and fluoroquinolones while all 
the remaining CRE that they studied were multidrug-
resistant [14]. Similar to this S. marcescens isolates in 
our study were found susceptible to AMK, GEN, CIP, 
and SXT. Only one S. marcescens in our study was mul-
tidrug-resistant. Similar to this E. aerogenes strains in 
our study were mostly susceptible to AMK, GEN, CIP, 
SXT and CST and only one of E. aerogenes strains was 
multidrug-resistant.
Fursova et al. showed that most of the CRE strains they 
studied were multidrug-resistant (98.9  % of K. pneumo-
niae and 100  % of P. mirabilis). They found that most 
active antibiotic against K. pneumoniae was CST and 
most effective antibiotics against P. mirabilis were cefop-
erazone/sulbactam, ERT, and CAZ [25]. Similar to this 
we found most effective antibiotics against carbapenem-
resistant P. mirabilis were CXM, CAE, FOX, CRO, ERT, 
and AMK.
Conclusions
The findings of our study indicate that OXA-48 resist-
ance is spreading rapidly throughout many Enterobacte-
riaceae species in Turkey. Also, NDM-1 isolates without 
a history of foreign contact are increasingly being found 
in our country. This is alarming. Therefore, carbapenem 
resistance mechanisms in Enterobacteriaceae should be 
rapidly determined and infection control precautions 
should be immediately taken.
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